[Treatment of psoriatic rheumatism with a retinoid derivative: etretinate. Open preliminary trial on 12 patients reviewed after 6 months].
D005050:Etretinate / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D013997:Time Factors
D005050:Etretinate
Traitement du rhumatisme psoriasique par un dérivé rétinoïde: l'étrétinate. Essai préliminaire ouvert sur 12 malades revus à 6 mois.